This Australian Investors Podcast episode features Kanish Chugh from ETF Securities. In this short conversation, Owen and Kanish talk about the global healthcare and biotechnology thematic, including the ETF Securities' CURE ETF (ASX: CURE) and key companies operating in the sector. This chat is designed to be easy listening and help you get some ideas on your watchlist. It's just a short episode from Rask to see us into the new financial year before we step it up a gear. To learn more about the CURE ETF, follow this link: https://bit.ly/cure-aip View more episodes: https://bit.ly/Australian-Investors-Podcast Episode recorded: May 26th, 2021 INFORMATION WARNING Please note: ETF Securities is the issuer of CURE ETF, and guests appearing on the show may have an interest in some of the shares mentioned. Kanish works for ETF Securities. In short, always consider the risks of investing and read the Product Disclosure Statement (PDS). This podcast contains general financial advice only, issued by The Rask Group Pty Ltd. You can view our Financial Services Guide (FSG) on the www.rask.com.au/fsg webpage. The information/advice in this podcast does not take into account your needs, goals or objectives, so speak with a licensed and trusted financial adviser before acting on it. Any performance metrics cited in this podcast should be considered hypothetical as the performance may not be accurate at the date you listen to the episode. Past performance is not indicative of future performance. Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related